Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Ferro

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Nutrients|September 15, 2020
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro, Francesco Baratta, Daniele Pastori, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone DiseaseFrancesco Baratta, Daniele Pastori, Nicholas Cocomello, et al.
International Journal of Molecular Sciences|March 11, 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular RiskFrancesco Baratta, Nicholas Cocomello, Mattia Coronati, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2007
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillationDomenico Ferro, Lorenzo Loffredo, Licia Polimeni, et al.
World Journal of Gastroenterology|August 23, 2019
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?Francesco Baratta, Daniele Pastori, Domenico Ferro, et al.
Journal of the American College of Cardiology|January 5, 2005
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemiaValerio Sanguigni, Domenico Ferro, Pasquale Pignatelli, et al.
International Journal of Environmental Research and Public Health|September 10, 2021
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio StudyFrancesco Baratta, Domenico Ferro, Daniele Pastori, et al.
Cardiovascular Research|February 19, 2008
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failurePasquale Pignatelli, Roberto Cangemi, Andrea Celestini, et al.
Circulation. Arrhythmia and Electrophysiology|February 25, 2012
Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversionDomenico Ferro, Pasquale Franciosa, Roberto Cangemi, et al.
Circulation|February 3, 2005
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patientsValerio Sanguigni, Pasquale Pignatelli, Luisa Lenti, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Nutrients|September 15, 2020
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressDomenico Ferro, Francesco Baratta, Daniele Pastori, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Sex-Related Differences in the Association between Metabolic Syndrome and Gallstone DiseaseFrancesco Baratta, Daniele Pastori, Nicholas Cocomello, et al.
International Journal of Molecular Sciences|March 11, 2023
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular RiskFrancesco Baratta, Nicholas Cocomello, Mattia Coronati, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2007
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillationDomenico Ferro, Lorenzo Loffredo, Licia Polimeni, et al.
World Journal of Gastroenterology|August 23, 2019
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?Francesco Baratta, Daniele Pastori, Domenico Ferro, et al.
Journal of the American College of Cardiology|January 5, 2005
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemiaValerio Sanguigni, Domenico Ferro, Pasquale Pignatelli, et al.
International Journal of Environmental Research and Public Health|September 10, 2021
Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio StudyFrancesco Baratta, Domenico Ferro, Daniele Pastori, et al.
Cardiovascular Research|February 19, 2008
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failurePasquale Pignatelli, Roberto Cangemi, Andrea Celestini, et al.
Circulation. Arrhythmia and Electrophysiology|February 25, 2012
Serum levels of vitamin E are associated with early recurrence of atrial fibrillation after electric cardioversionDomenico Ferro, Pasquale Franciosa, Roberto Cangemi, et al.
Circulation|February 3, 2005
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patientsValerio Sanguigni, Pasquale Pignatelli, Luisa Lenti, et al.
Pageof 3